Nu-Med Plus, Inc. (NUMD) Financial Statements (2026 and earlier)

Company Profile

Business Address 640 BELLE TERRE RD. 2 E
PORT JEFFERSON, NY 11777
State of Incorp. UT
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1277312189
Cash and cash equivalent1277312189
Prepaid expense7776 349
Total current assets:89138012538
Noncurrent Assets
Operating lease, right-of-use asset     88
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization(84)  90212
Other undisclosed noncurrent assets84  (90)  
Total noncurrent assets:     1020
TOTAL ASSETS:89138022557
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities665814812052
Accounts payable4843872826
Accrued liabilities1815619326
Debt100100100100  
Due to related parties342620
Other undisclosed current liabilities1136746 88
Total current liabilities:27922416014315580
Noncurrent Liabilities
Long-term debt and lease obligation      9
Long-term debt, excluding current maturities      9
Total noncurrent liabilities:      9
Total liabilities:27922416014315589
Equity
Equity, attributable to parent, including:(271)(215)(147)(63)(132)468
Common stock848484817951
Common stock, share subscribed but unissued, subscriptions receivable      (724)
Common stock, value, subscriptions      724
Additional paid in capital9,5959,5959,5959,5559,3588,432
Accumulated deficit(9,950)(9,893)(9,825)(9,699)(9,569)(8,739)
Other undisclosed equity, attributable to parent      724
Total equity:(271)(215)(147)(63)(132)468
TOTAL LIABILITIES AND EQUITY:89138022557

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues    529 
Other income   (5)529(14)
Gross profit:    529 
Operating expenses(49)(63)(121)(182)(839)(1,995)
Other operating expense, net
(Other Expenses)
    (1)  
Other undisclosed operating income (loss)   5(52)(9)14
Operating loss:(49)(63)(121)(182)(839)(1,995)
Nonoperating expense(7)(5)    
Interest and debt expense(7)(5) 499(14)
Loss from continuing operations before equity method investments, income taxes:(63)(73)(121)(133)(830)(2,009)
Other undisclosed income (loss) from continuing operations before income taxes75(5)3  
Loss from continuing operations:(56)(68)(126)(130)(830)(2,009)
Loss before gain (loss) on sale of properties:(830)(2,009)
Net loss:(56)(68)(126)(130)(830)(2,009)
Other undisclosed net income attributable to parent      
Net loss available to common stockholders, diluted:(56)(68)(126)(130)(830)(2,009)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(56)(68)(126)(130)(830)(2,009)
Comprehensive loss, net of tax, attributable to parent:(56)(68)(126)(130)(830)(2,009)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: